Bacteria slow down, and the drugs that kill fast-growers simply fail.
In the quiet persistence of a wound that will not close, bacteria have long found refuge in the body's own oxygen-starved depths — a biological blind spot that has confounded medicine for decades. Researchers at the University of Oregon have now discovered that chlorate, a simple and long-familiar compound, can be combined with standard antibiotics to become ten thousand times more lethal to the bacteria most responsible for chronic wound infections. The finding does not yet belong to the clinic, but it belongs to a larger story humanity has been writing for generations: that the tools for healing are sometimes already in hand, waiting only for the right question to be asked.
- One in four Type 2 diabetics develops a chronic wound, and one in five severe cases ends in amputation — a quiet epidemic hiding in plain sight.
- Conventional antibiotics are calibrated for fast-growing bacteria in oxygen-rich environments, leaving slow-metabolizing pathogens in low-oxygen wounds effectively invisible to treatment.
- University of Oregon researchers found that chlorate hijacks the very survival mechanism bacteria use in oxygen-starved wounds, destabilizing them so thoroughly that antibiotics can finish the job at just one percent of the standard dose.
- The synergy between chlorate and antibiotics was invisible in traditional high-oxygen drug screening — raising urgent questions about how many other effective combinations have already been overlooked.
- Human trials remain years away, with complex polymicrobial wound environments and an unexplained biological mechanism still to be understood before the lab finding can become a clinical tool.
A diabetic foot ulcer begins as something small — a blister, a pressure sore that refuses to close. For roughly one in four people with Type 2 diabetes, it becomes a chronic open wound. When infection takes hold, the body's own biology turns against healing: blood flow falters, oxygen runs thin, and bacteria shift their metabolism to survive on nitrate instead, growing slowly and stubbornly in the depths. That slow growth is precisely the problem. Most antibiotics are designed and tested against fast-growing bacteria in oxygen-rich conditions. Against slow-moving pathogens in low-oxygen wounds, they fail — and one in five severe cases ends in amputation.
Researchers at the University of Oregon have found a way to flip this dynamic. Published in Applied and Environmental Microbiology, their laboratory tests show that adding chlorate — a simple, well-known compound — to standard antibiotics makes the combination ten thousand times more potent against Pseudomonas aeruginosa, the bacterium most commonly responsible for chronic wound infections. The synergy is so powerful that just one percent of a standard antibiotic dose retains full killing power. The work was led by Melanie Spero, an assistant professor of biology who first explored chlorate's potential at Caltech and has since refined the approach in her own lab.
What makes the discovery striking is the ordinariness of its ingredients. Neither chlorate nor the antibiotics do much against resistant bacteria on their own. But together, they appear to hijack the bacteria's nitrate respiration — the very mechanism that allows survival in low-oxygen wounds — destabilizing cells so thoroughly that antibiotics can finish the job. The exact mechanism remains unclear, a gap Spero is determined to close.
The practical stakes are real. Patients with chronic wound infections often spend months on high-dose antibiotics, a regimen that disrupts the gut microbiome, causes severe side effects, and risks toxicity. If this finding translates to human treatment, shorter courses at lower doses could reduce that collateral damage considerably. But the road from petri dish to clinic is long. So far, testing has been confined to cell cultures and diabetic mouse models — not the complex, multi-species microbial communities that inhabit real wounds. Years of further research lie ahead.
Perhaps most consequentially, the work exposes a flaw in how drugs have long been screened. Chlorate has been known to scientists for decades, but its effects are invisible in the high-oxygen conditions used in standard testing. The question Spero is now asking — what cellular processes can be stressed to make bacteria collapse in the presence of antibiotics — could open a new design logic for drug combinations, one built on understanding rather than trial and error. As antibiotic resistance spreads, finding ways to make existing drugs work harder and smarter may prove as important as discovering new ones.
A diabetic foot ulcer starts small—a blister, a pressure sore on the sole of the foot that won't close. For roughly one in four people with Type 2 diabetes, it becomes an open wound. For more than half of those, infection sets in. And when infection takes hold in a chronic wound, the body's own biology works against healing. Blood flow falters. Inflammatory cells demand oxygen the tissue cannot deliver. Bacteria settle in and shift their metabolism to survive on nitrate instead, growing slowly, stubbornly, in the oxygen-starved depths. That slow growth is the problem. Most antibiotics are tested and rated on their ability to kill fast-growing bacteria in oxygen-rich conditions. Against slow-moving pathogens in low-oxygen wounds, they fail. The bacteria survive. The infection persists. One in five severe diabetic foot ulcers end in amputation.
Researchers at the University of Oregon have found a way to flip this dynamic. In laboratory tests published September 29 in Applied and Environmental Microbiology, they demonstrated that adding a simple molecule called chlorate to standard antibiotics makes them ten thousand times more potent against Pseudomonas aeruginosa, the bacterium most commonly responsible for chronic wound infections. The combination works so efficiently that doctors could use just one percent of the standard antibiotic dose and still kill the pathogen. The finding emerged from years of work by Melanie Spero, an assistant professor of biology at Oregon, who first explored chlorate's potential while at Caltech and has since refined the approach in her own lab.
What makes this discovery significant is not the novelty of either component. Chlorate is a simple, well-known compound. The antibiotics are already on pharmacy shelves. Neither substance does much against resistant bacteria on its own. But together, in the right proportions, they stress bacterial cells in ways that render them vulnerable to drugs that would otherwise bounce off them harmlessly. Spero's team found that chlorate somehow hijacks the bacteria's nitrate respiration—the very mechanism that lets them survive in low-oxygen wounds—and destabilizes them so thoroughly that antibiotics can finish the job. The exact mechanism remains unclear, a gap Spero is determined to close.
The practical implications are substantial. Patients with chronic wound infections often spend months on antibiotics, a regimen that exacts a toll. High-dose, long-term antibiotic therapy disrupts the gut microbiome, triggers severe side effects, and increases the risk of toxicity. If this lab finding translates to human treatment, patients could spend less time on medication at lower doses, reducing collateral damage to their bodies while still clearing the infection. "Anything we can do to shorten the amount of time that a person is going to be on antibiotics and lower the dosage, the better," Spero said.
But the path from petri dish to clinic is long. The research so far has been conducted in controlled cell cultures and diabetic mouse models. Real chronic wounds are not monocultures. They host entire microbial neighborhoods—multiple species living and interacting in complex ways. Testing how chlorate-antibiotic combinations affect these polymicrobial communities in living organisms is the obvious next step, one that will take years. Spero is also hunting for the biological mechanism that makes chlorate and antibiotics synergistic, a mystery that could unlock rational design of other drug combinations rather than relying on trial and error.
What intrigues Spero most is what the research reveals about how we test drugs. Chlorate has been known to scientists for decades, but it was overlooked in traditional screening because those tests are run in high-oxygen conditions where chlorate's effects are invisible. "We need to be asking what processes are being pushed on or stressed out in the cell," Spero said, "that can lead to its collapse in the presence of antibiotics." If researchers can understand the cellular machinery behind this synergy, they may be able to design new molecules that trigger similar effects. The implications extend far beyond chronic wounds. As antibiotic resistance spreads across infectious diseases, finding ways to make existing drugs work harder—and smarter—could reshape how medicine fights back.
Notable Quotes
Drug combinations will be a critical approach that helps us fight against the rise of antibiotic resistance. Finding examples of synergy among antimicrobials already on the market is going to be really valuable.— Melanie Spero, assistant professor of biology, University of Oregon
Anything we can do to shorten the amount of time that a person is going to be on antibiotics and lower the dosage, the better.— Melanie Spero
The Hearth Conversation Another angle on the story
Why does a chronic wound become so hard to treat? It seems like antibiotics should just work.
The wound itself creates the problem. When tissue doesn't heal normally, blood flow drops, inflammatory cells consume oxygen, and bacteria move in. The bacteria then switch to a different way of breathing—using nitrate instead of oxygen. They grow slowly, almost dormant, in that low-oxygen environment.
And slow-growing bacteria are resistant to antibiotics?
Not resistant in the genetic sense. But most antibiotics are designed and tested against fast-growing bacteria in oxygen-rich conditions. When bacteria slow down, those drugs become ineffective. It's like testing a car's brakes only on dry pavement, then wondering why they fail on ice.
So chlorate somehow fixes that?
It stresses the bacterial cell in a way we don't fully understand yet. It interferes with the bacteria's nitrate respiration—the very mechanism keeping them alive in low-oxygen wounds. That stress makes them suddenly vulnerable to antibiotics that would normally bounce off them.
And you can use a hundredth of the normal dose?
One percent of the standard dose in our lab tests. That matters because long-term antibiotics destroy the gut microbiome and cause serious side effects. Shorter treatment at lower doses could spare patients a lot of harm.
What's the catch?
We've only tested this in cell cultures and mouse models. Real chronic wounds contain dozens of bacterial species living together. We need to see if the combination works against that complexity. And we still don't know exactly why chlorate and antibiotics work together. Until we do, we're still guessing.